Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VZV Antikörper

VZV Reaktivität: Varicella Zoster Virus (VZV) IF, IHC (fro) Wirt: Maus Monoclonal 371 unconjugated
Produktnummer ABIN180987
  • Target Alle VZV Produkte
    VZV (Varicella Zoster Virus (VZV))
    Reaktivität
    • 2
    • 1
    Varicella Zoster Virus (VZV)
    Wirt
    • 3
    Maus
    Klonalität
    • 3
    Monoklonal
    Konjugat
    • 3
    Dieser VZV Antikörper ist unkonjugiert
    Applikation
    • 3
    • 2
    • 2
    • 2
    Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Produktmerkmale
    Synonyms: Varicella-zoster virus, Human herpesvirus 3, Varicella Zoster Virus nucleocapsid
    Aufreinigung
    Purified
    Klon
    371
    Isotyp
    IgG1
  • Applikationshinweise
    Immunofluorescence: 1/10-1/50. Immunohistochemistry on Frozen Sections: 1/10-1/50.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.1 mg/mL
    Buffer
    PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.
    Haltbarkeit
    12 months
  • Target
    VZV (Varicella Zoster Virus (VZV))
    Andere Bezeichnung
    VZV / HHV-3 (VZV Produkte)
    Substanzklasse
    Virus
    Hintergrund
    The varicella-zoster virus is one of the eight herpesviruses known to affect humans (and other vertebrates). Primary VZV infection results in chickenpox (varicella), which may rarely result in complications including VZV encephalitis. Even when clinical symptoms of varicella have resolved, VZV remains dormant in the nervous system of the host in the trigeminal and dorsal root ganglia. In about 10-20 % of cases, VZV later reactivates later in life to produce herpes zoster (shingles) and its associated sequelae including post-herpetic neuralgia, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form.Synonyms: HHV3, Varizella zoster
Sie sind hier:
Kundenservice